share_log

Sichuan Kelun Pharmaceutical Gets China Clinical Trial Nod for Anti-Tumor Drug

Sichuan Kelun Pharmaceutical Gets China Clinical Trial Nod for Anti-Tumor Drug

四川 科倫藥業 因抗腫瘤藥物獲得中國臨床試驗批准
MT Newswires ·  2024/12/05 18:10

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論